Sanara MedTech (SMTI) Non-Current Assets (2010 - 2026)
Sanara MedTech's (SMTI) quarterly Non-Current Assets came in at $38.1 million in Q1 2026, down 36.04% YoY from $59.5 million in Q1 2025, and down 3.36% on a QoQ basis from $39.4 million in Q4 2025.
Sanara MedTech (SMTI) Non-Current Assets (2010 - 2026) Analysis & Trends
Sanara MedTech (SMTI) has 16 years of Non-Current Assets data on file, last reported at $38.1 million in Q1 2026.
- Quarterly Non-Current Assets fell 36.04% year-over-year to $38.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.1 million (down 36.04% YoY) and the FY2025 annual result came in at $39.4 million, down 28.08% from the prior year.
- Non-Current Assets retreated to $38.1 million in Q1 2026, from $39.4 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $65.1 million in Q2 2025 to a low of $11.4 million in Q1 2022.
- A 5-year average of $45.4 million and a median of $41.0 million in 2023 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets soared 282.34% — and 2026, when it tumbled 36.04%.
- Tracing SMTI's Non-Current Assets over 5 years: stood at $40.4 million in 2022, then soared by 35.74% to $54.9 million in 2023, then decreased by 0.14% to $54.8 million in 2024, then declined by 28.08% to $39.4 million in 2025, then slipped by 3.36% to $38.1 million in 2026.
- The last three Non-Current Assets figures came in at $38.1 million (Q1 2026), $39.4 million (Q4 2025), and $39.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 11.33 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 42.59 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 24.47 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 4.64 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 27.61 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 10.50 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 10.18 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 12.80 Bn |
| 10 | Sanara MedTech | 297.82 Mn | 297.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.08 Mn |
| Dec 31, 2025 | 39.40 Mn |
| Sep 30, 2025 | 39.86 Mn |
| Jun 30, 2025 | 65.10 Mn |
| Mar 31, 2025 | 59.54 Mn |
| Dec 31, 2024 | 54.79 Mn |
| Sep 30, 2024 | 56.64 Mn |
| Jun 30, 2024 | 52.57 Mn |
| Mar 31, 2024 | 53.73 Mn |
| Dec 31, 2023 | 54.87 Mn |
| Sep 30, 2023 | 56.10 Mn |
| Jun 30, 2023 | 40.10 Mn |
| Mar 31, 2023 | 40.96 Mn |
| Dec 31, 2022 | 40.42 Mn |
| Sep 30, 2022 | 40.90 Mn |
| Jun 30, 2022 | 26.65 Mn |
| Mar 31, 2022 | 11.44 Mn |
| Dec 31, 2021 | 11.79 Mn |
| Sep 30, 2021 | 10.70 Mn |
| Jun 30, 2021 | 9.87 Mn |